Molecular characterization of HAMP rs10421768 gene and phenotypic expression of hepcidin; a case-control study among sickle cell anaemia patients in Ghana
Open Access
- 27 June 2024
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (6) , e0306194
Abstract
Background: The sporadic nature of blood transfusion therapy coupled with the alteration of HAMP genes may exacerbate the risk of iron burden in sickle cell anaemia (SCA) patients. The study determined the polymorphic distribution of the HAMP promoter gene rs10421768 and hepcidin levels in SCA patients. Method: Sixty participants aged ≥12years [45 SCA patients and 15 controls (HbA)] were recruited from 15th March, 2023 to 20th July, 2023 for a case-control study at Methodist Hospital Wenchi, Ghana. Complete blood count and hepcidin levels assessment were done using haematology analyzer and ELISA, respectively. Genomic DNA was extracted using the Qiagen Kit, and HAMP gene rs10421768 (c.-582 A>G) was sequenced using the MassARRAY method. Data were analysed using SPSS version 26.0. Results: The frequencies of the HAMP promoter rs10421768 genotypes AA, AG, and GG were 64.4%, 33.3%, and 2.2% in SCA patients, and 86.7%, 13.3%, and 0% in the controls, respectively. Serum hepcidin levels were significantly higher among controls than cases [204.0 (154.1–219.3) vs 150.2 (108.1–195.6)μg/L, pp0.05). Conclusion: The HAMP promoter rs10421768 AA genotype has the highest frequency of distribution and the GG genotype with the least distribution. Participants with HAMP rs10421768 G allele (c.-582A>G) had reduced levels of hepcidin. HAMP rs10421768 genotypes had no association with blood cell parameters and disease severity. The HAMP rs10421768 genotypes may influence serum levels of hepcidin. Further study is required to elucidate the potential effect of the G allele on hepcidin transcription.Keywords
This publication has 28 references indexed in Scilit:
- Novel Insights and Future Perspective in Iron Metabolism and AnemiaMetabolites, 2022
- Serum Hepcidin Hormone Level and Its Genes Polymorphism2021
- Hepcidin gene polymorphisms and iron overload in β-thalassemia major patients refractory to iron chelating therapyBMC Medical Genetics, 2020
- Sickle cell disease: Clinical presentation and management of a global health challengeBlood Reviews, 2019
- Burden of Sickle Cell Disease in Ghana: The Korle-Bu ExperienceAdvances in Hematology, 2018
- Influence of Hepcidin in the Development of Anemia2018
- Sickle cell diseaseThe Lancet, 2017
- Association of hepcidin promoter c.-582 A>G variant and iron overload in thalassemia majorHaematologica, 2009
- A new mutation in the hepcidin promoter impairs its BMP response and contributes to a severe phenotype in HFE related hemochromatosisHaematologica, 2009
- Acute phase reactants and severity of homozygous sickle cell diseaseJournal of Internal Medicine, 1993